Leucocin A (18-35)[E3R;S6R;A7R;G8,16L;H10R;N14,17R;G18R]
General Information
DRACP ID DRACP00655
Peptide Name Leucocin A (18-35)[E3R;S6R;A7R;G8,16L;H10R;N14,17R;G18R]
Sequence WGRAFRRLVRRLARGLRR
Sequence Length 18
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HepG2 | Hepatoblastoma | Blastoma | IC50=32µM | MTT assay | 24h | 1 |
Hemolytic Activity Human erythrocytes:10% Hemolysis>55.78µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C101H175N43O19
Absent amino acids CDEHIKMNPQSTY
Common amino acids R
Mass 259917
Pl 13.35
Basic residues 8
Acidic residues 0
Hydrophobic residues 8
Net charge 8
Boman Index -8975
Hydrophobicity -87.22
Aliphatic Index 92.22
Half Life
Mammalian: 2.8 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 323.53
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 28002968
Title Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical Peptide Amphiphiles
Doi 10.1021/acs.jmedchem.6b00922
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available